Regulatory Requirements, Business Incentives 15 Jan 2025 compliance, procurement, government, supply chain, manufacturing, semiconductors, it, domestic

🔗RFI on Domestic Semiconductor Manufacturing & Procurement Strategies

This request for information (RFI) seeks input on ways the Federal Government can build the resilience of domestic semiconductor manufacturing and maintain this essential capability through the procurement of commercial IT end products that include semiconductors fabricated in the United States. Specific feedback is sought on potential procurement approaches to minimize supply chain disruption and increase fabrication of semiconductors in the United States.

Learn More
Regulatory Compliance, Business Incentive 14 Jan 2025 manufacturing, foreign-trade zones, missouri, subzone, true manufacturing co.
Compliance, Environmental Regulation, Workplace Safety 14 Jan 2025 compliance, environmental protection, chemicals, epa, reporting and recordkeeping requirements, environmental regulations, manufacturing, hazardous substances, workplace safety, c.i. pigment violet 29, pv29

⚖️EPA Proposes Regulation for C.I. Pigment

The Environmental Protection Agency (EPA or Agency) is proposing to address the unreasonable risk of injury to human health presented by C.I. Pigment Violet 29 (CASRN 81-33-4, also known as PV29), under its conditions of use as documented in EPA's January 2021 Risk Evaluation for PV29 and the September 2022 Revised Risk Determination for PV29 prepared under TSCA. TSCA requires that EPA address by rule any unreasonable risk of injury to health or the environment identified in a TSCA risk evaluation and apply requirements to the extent necessary so the chemical no longer presents unreasonable risk. To address the identified unreasonable risk, EPA is proposing requirements to protect workers from the unreasonable risk of PV29 during manufacturing and processing, certain industrial and commercial uses of the chemical, and disposal, while also allowing for a reasonable transition period prior to enforcement of said requirements.

Learn More
Compliance, Regulatory Requirements 7 Jan 2025 compliance, regulations, fda, supply chain, manufacturing, medical devices

📜FDA Guidance on Device Manufacturing Discontinuances and Notifications

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act." This guidance updates the previous version of the guidance, of the same title, issued on November 17, 2023, and finalizes the concurrently issued draft guidance entitled "Select Updates for the 506J Guidance: 506J Device List and Additional Notifications." This guidance finalizes a list of device product codes for which a manufacturer of such devices is required to notify FDA in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act) (hereafter referred to as the "506J Device List") and clarifies that manufacturers may submit voluntary notifications regarding supply chain issues at any time, unrelated to the declaration or potential declaration of a public health emergency (PHE).

Learn More
Regulatory Compliance, Industry Standards 6 Jan 2025 compliance, fda, manufacturing, guidance, drug products, pharmaceutical

💊FDA Draft Guidance on Complying with 21 CFR 211.110 Available

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Considerations for Complying With 21 CFR 211.110." This guidance, when finalized, will describe considerations for complying with the requirements for ensuring batch uniformity and drug product integrity. In addition, this guidance discusses related quality considerations for drug products that are manufactured using advanced manufacturing. FDA is committed to supporting and enabling pharmaceutical innovation and modernization as part of the Agency's mission to protect and promote the public health. FDA encourages industry representatives and manufactures who are interested in using innovative control strategies to contact the Agency.

Learn More
Compliance, Business Incentives, Trade 2 Jan 2025 compliance, kentucky, trade regulations, manufacturing, go pro, ftz, foreign-trade zone, electronics, production activity
Compliance, Financial Impact 3 Jan 2025 regulations, commerce, trade, antidumping, japan, manufacturing

📊Antidumping Duty Order on Welded Pipe from Japan – Implications

The U.S. Department of Commerce (Commerce) finds that revocation of the antidumping duty (AD) order on welded large diameter line pipe (line pipe) from Japan would be likely to lead to continuation or recurrence of dumping at the levels indicated in the "Final Results of Sunset Review" section of this notice.

Learn More
Compliance Requirements, Industry Regulations 3 Jan 2025 compliance, regulations, vehicle safety, seat belts, imports, motor vehicle safety, motor vehicles, manufacturing

🚗New Seat Belt Warning System Regulations for Vehicle Manufacturers

This document amends Federal Motor Vehicle Safety Standard (FMVSS) No. 208, "Occupant crash protection," to require a seat belt use warning system for rear seats. The rule also updates and enhances the current seat belt warning requirements for the driver's seat belt and extends these requirements to the front outboard passenger seat. The final rule applies (with some exceptions) to passenger cars, trucks, most buses, and multipurpose passenger vehicles with a gross vehicle weight rating of 4,536 kilograms (10,000 pounds) or less. This document also makes related amendments to FMVSS No. 101, "Controls and displays."

Learn More
Regulatory Compliance, Environmental Health 3 Jan 2025 compliance, epa, tsca, formaldehyde, manufacturing, health risk, chemical regulation

⚠️EPA Final Risk Evaluation for Formaldehyde

The Environmental Protection Agency (EPA or Agency) is announcing the availability of the final risk evaluation under the Toxic Substances Control Act (TSCA) for formaldehyde. The purpose of risk evaluations under TSCA is to determine whether a chemical substance presents an unreasonable risk of injury to health or the environment, without consideration of costs or non-risk factors, including unreasonable risk to potentially exposed or susceptible subpopulations identified as relevant to the risk evaluation by EPA, under the conditions of use. The Agency used the best available science to prepare this final risk evaluation and has determined, based on the weight of scientific evidence, that formaldehyde presents an unreasonable risk of injury to human health. Under TSCA, EPA must initiate risk management actions to address the unreasonable risk.

Learn More